Literature DB >> 19481142

Acute methamphetamine exposure inhibits cardiac contractile function.

Subat Turdi1, Robbie M Schamber, Nathan D Roe, Herbert G Chew, Bruce Culver, Jun Ren.   

Abstract

Methamphetamine, a commonly seen substance of abuse, has been reported to exert detrimental effect on bodily function including the cardiovascular system although its mechanism of action is poorly understood. This study was designed to examine the direct impact of methamphetamine on isolated whole heart and single cardiomyocyte contractile function. Murine hearts and isolated cardiomyocytes from adult FVB mice were exposed to various concentrations of methamphetamine for 30min prior to the assessment of mechanical function using a Langendroff apparatus and an IonOptix Myocam system, respectively. Cardiac contractile properties analyzed included maximal velocity of left ventricular pressure development and decline (+/-dP/dt), peak shortening amplitude (PS), maximal velocity of shortening/relengthening (+/-dLdt), time-to-PS (TPS), time-to-90% relengthening (TR(90)), resting and electrically stimulated increase of intracellular Ca(2+) as well as intracellular Ca(2+) decay. Our results revealed that acute methamphetamine exposure depressed +/-dP/dt, PS and rise of intracellular Ca(2+) without affecting +/-dLdt, TPS, TR(90), resting intracellular Ca(2+) and intracellular Ca(2+) decay. Furthermore, methamphetamine nullified the adrenergic agonist norepinephrine-elicited positive cardiomyocyte contractile response, including elevated PS, +/-dLdt and shortened TR(90) without affecting TPS. Western blot analysis showed unchanged expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a) and phospholamban, associated with upregulated Na(+)-Ca(2+) exchanger levels following acute methamphetamine exposure. In addition, methamphetamine promoted overt cardiomyocyte protein damage evaluated by carbonyl formation. Taken together, these results demonstrate direct cardiac depressant effect of methamphetamine in myocardium and isolated cardiomyocytes, possibly associated with protein damage and dampened adrenergic response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481142      PMCID: PMC2730117          DOI: 10.1016/j.toxlet.2009.05.015

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  21 in total

1.  Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation.

Authors:  Y Wang; T Hayashi; C F Chang; Y H Chiang; L I Tsao; T P Su; C Borlongan; S Z Lin
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

2.  History of the methamphetamine problem.

Authors:  M D Anglin; C Burke; B Perrochet; E Stamper; S Dawud-Noursi
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

3.  Reversible dilated cardiomyopathy induced by methamphetamine.

Authors:  L J Jacobs
Journal:  Clin Cardiol       Date:  1989-12       Impact factor: 2.882

4.  Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice.

Authors:  S Z Imam; Y Itzhak; J L Cadet; F Islam; W Slikker; S F Ali
Journal:  Brain Res Mol Brain Res       Date:  2001-07-13

Review 5.  Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.

Authors:  C Davidson; A J Gow; T H Lee; E H Ellinwood
Journal:  Brain Res Brain Res Rev       Date:  2001-08

6.  Cardiac lesions and their reversibility after long term administration of methamphetamine.

Authors:  M N Islam; H Kuroki; B Hongcheng; Y Ogura; N Kawaguchi; S Onishi; C Wakasugi
Journal:  Forensic Sci Int       Date:  1995-08-28       Impact factor: 2.395

7.  Working heart function in diabetes is not improved by spironolactone treatment.

Authors:  Subodh Verma; Violet G Yuen; Mitesh Badiwala; Todd J Anderson; John H McNeill
Journal:  Can J Physiol Pharmacol       Date:  2003-05       Impact factor: 2.273

8.  Inhibitory mechanism of methamphetamine in the isolated myocardium of bullfrog.

Authors:  M Urabe
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-06

9.  Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

Authors:  Mevan Wijetunga; Todd Seto; Joseph Lindsay; Irwin Schatz
Journal:  J Toxicol Clin Toxicol       Date:  2003

10.  Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice.

Authors:  Qianli Yu; Sergio Montes; Douglas F Larson; Ronald R Watson
Journal:  Life Sci       Date:  2002-07-12       Impact factor: 5.037

View more
  8 in total

1.  Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations.

Authors:  Haley L Yarosh; Shashwath A Meda; Harriet de Wit; Amy B Hart; Godfrey D Pearlson
Journal:  Psychopharmacology (Berl)       Date:  2015-04-07       Impact factor: 4.530

2.  The emergence of cardiac changes following the self-administration of methamphetamine.

Authors:  Jessica L Freeling; Lisa M McFadden
Journal:  Drug Alcohol Depend       Date:  2020-04-23       Impact factor: 4.492

Review 3.  Methamphetamine Use and Cardiovascular Disease.

Authors:  Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

Review 4.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

5.  Sex influences susceptibility to methamphetamine cardiomyopathy in mice.

Authors:  Marie C Marcinko; April L Darrow; Aaron J Tuia; Ralph V Shohet
Journal:  Physiol Rep       Date:  2019-03

6.  SERCA2a ameliorates cardiomyocyte T-tubule remodeling via the calpain/JPH2 pathway to improve cardiac function in myocardial ischemia/reperfusion mice.

Authors:  Shuai Wang; You Zhou; Yuanyuan Luo; Rongsheng Kan; Jingwen Chen; Haochen Xuan; Chaofan Wang; Junhong Chen; Tongda Xu; Dongye Li
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Report of methamphetamine use and cardiomyopathy in three patients.

Authors:  Roxana Sadeghi; Khosro Agin; Maryam Taherkhani; Leila Najm-Afshar; Lewis S Nelson; Mohammad Abdollahi; Shahin Shadnia
Journal:  Daru       Date:  2012-08-30       Impact factor: 3.117

8.  Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function.

Authors:  Chowdhury S Abdullah; Richa Aishwarya; Shafiul Alam; Mahboob Morshed; Naznin Sultana Remex; Sadia Nitu; Gopi K Kolluru; James Traylor; Sumitra Miriyala; Manikandan Panchatcharam; Brandon Hartman; Judy King; Mohammad Alfrad Nobel Bhuiyan; Sunitha Chandran; Matthew D Woolard; Xiuping Yu; Nicholas E Goeders; Paari Dominic; Connie L Arnold; Karen Stokes; Christopher G Kevil; A Wayne Orr; Md Shenuarin Bhuiyan
Journal:  Commun Biol       Date:  2020-11-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.